Catalent announced organizational changes within its biologics business.
Tedd Green, former President of Cook Pharmica, will become Senior Vice President of Catalent Biologics, and will have responsibility for the entire biologics business. He will continue to report to Barry Littlejohns, President, Catalent Biologics and Specialty Drug Delivery, and will also act as a member of Catalent’s Executive Leadership Team. Green will be based at the Bloomington facility.
Mike Riley will become Vice President and General Manager of Drug Substance and Bioanalytical services for Catalent Biologics. He will lead the company’s biologics manufacturing business, including its mammalian cell-line engineering and biomanufacturing capabilities, and its broad bioanalytical capabilities based at several sites across Catalent’s global network.
Cory Lewis will take on the new role of Vice President and General Manager of the Catalent Biologics Drug Product business, with a focus on successfully growing the Catalent Biologics drug product offerings both in the U.S. and in Europe.
In a further move, Ryan Hawkins has been appointed as General Manager of the Bloomington site.